MP

Mallikarjunan Praveen

Active Director Partner DIN 09153908
DIN 09153908 First appointment Apr 2021
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 1 historical roles
Total affiliations 2 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mallikarjunan Praveen

Data last updated:

Mallikarjunan Praveen is a Partner at Spaderan Pharmaceuticals India Llp (since 2026). Earlier, Mallikarjunan Praveen was a Director at Rani Malli's Vision Private Limited (from 2021).

DIN 09153908
Primary Designation Partner
First Appointment 21 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner20 Jul 20262026Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rani Malli's Vision Private Limited U85110TN2021PTC142995
Director21 Apr 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Mallikarjunan Praveen

NameDINCompanyDesignation
Nantha KumarSpaderan Pharmaceuticals India LlpPartner
Palani KumarSpaderan Pharmaceuticals India LlpPartner
Sureshbabu08647068Spaderan Pharmaceuticals India LlpPartner
Manoharan AnandSpaderan Pharmaceuticals India LlpPartner
Murugesan DeepakSpaderan Pharmaceuticals India LlpPartner
Murugesan RamkumarSpaderan Pharmaceuticals India LlpPartner
Natesan SenthilkumarSpaderan Pharmaceuticals India LlpPartner
Ponnusamy AnbarasuSpaderan Pharmaceuticals India LlpPartner
Ragunath Ganesan DeebanSpaderan Pharmaceuticals India LlpPartner
Rajendran VinodhiniSpaderan Pharmaceuticals India LlpPartner
Ramalingam Padma DeviSpaderan Pharmaceuticals India LlpPartner
Ravindran SaravananSpaderan Pharmaceuticals India LlpPartner
Sengottaiyan ArunkumarSpaderan Pharmaceuticals India LlpPartner
Senthilkumar TharanyaSpaderan Pharmaceuticals India LlpPartner
Sriram Thanigai Davamani08646802Spaderan Pharmaceuticals India LlpPartner
Subramanyam SureshSpaderan Pharmaceuticals India LlpPartner
Sukanya PasinibilliSpaderan Pharmaceuticals India LlpPartner
Sundarajan Ramesh11838565Spaderan Pharmaceuticals India LlpDesignated Partner
Sureshkanna SasikalaSpaderan Pharmaceuticals India LlpPartner
Varudhappan Sugavanan10361415Spaderan Pharmaceuticals India LlpDesignated Partner
Venkatachalapathy RamyaSpaderan Pharmaceuticals India LlpPartner

Directorship timeline

Open interactive timeline →
Rani Malli's Vision Private Limited
Spaderan Pharmaceuticals India Llp
Premium access

Shareholding and investment profile for Mallikarjunan Praveen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mallikarjunan Praveen

Mallikarjunan Praveen currently holds 1 directorship: Spaderan Pharmaceuticals India Llp (Partner, since 20 Jul 2026).

Mallikarjunan Praveen was first appointed on 21 Apr 2021 as Director at Rani Malli's Vision Private Limited. The most recent appointment on record is 20 Jul 2026 at Spaderan Pharmaceuticals India Llp.

Mallikarjunan Praveen held 1 earlier board appointment: Rani Malli's Vision Private Limited (Director, from 21 Apr 2021).

The current boards of Mallikarjunan Praveen's companies include Nantha Kumar (Spaderan Pharmaceuticals India Llp), Palani Kumar (Spaderan Pharmaceuticals India Llp), Sureshbabu (Spaderan Pharmaceuticals India Llp), Manoharan Anand (Spaderan Pharmaceuticals India Llp), Murugesan Deepak (Spaderan Pharmaceuticals India Llp), Murugesan Ramkumar (Spaderan Pharmaceuticals India Llp), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available